When looking for companies to invest in, Larry Robbins (Trades, Portfolio) of Glenview Capital Management focuses on companies that are stable, predictable and steady. The company must have recurring revenue streams or entrenched market positions. His investing style is most commonly known as "GARP," which stands for Growth at a Reasonable Price.
Robbins currently has 74 stocks in his portfolio, valued at $19.97 billion with a quarter over quarter turnover rate of 13%. 34.7% of his portfolio are stocks from the healthcare sector, 19% come from the consumer cyclical sector and 10.7% are in technology.
Here's a look at the investor's most recent top buys:
Apollo Education Group Inc (APOL, Financial)
Robbins previously held APOL in his portfolio in 2010 and by 2012Q2, he sold all of his shares. During 2014Q4, he added the stock to his portfolio once again, which had a 0.92% impact on his overall portfolio after the transaction was made when he purchased 5,396,132 shares at an average price of $29.56/share.
Apollo was founded in Arizona in 1981 and offers educational programs and services, both online and on campus at various levels, including undergraduate, masters and doctorate.
The stock is currently trading at $26.82/share. The Peter Lynch earnings line is at $22.40, which means the stock may be overvalued.
Over the past 12 months, Apollo's earnings per share was $1.30 and earnings per share growth rate was -31.20%. The P/E ratio is 20.81
Revenue per share for the past 12 months was $25.90 and revenue per share growth rate was -14.20%.The company's revenue has been in a steady decline over the past five years.
The current P/B ratio is 2.46, which is close to the one-year low of 2.30.
Apollo's current ratio is at a comfortable 1.63, indicating good short-term financial strength.
Robbins purchased 2,884,331 shares of JAH at an average price of $43.56/share. This had a 0.69% impact on his overall portfolio.
Jarden Corp provides comsumer products under four business segments: Outdoor Solutions, Consumer Solutions, Branded Consumables and Process Solutions.
The stock is currently trading at $52.48/share. The Lynch earnings line gives the stock a value of $42.20, indicating the stock may be overvalued.
JAH's earnings per share over the past 12 months was $1.07 and Growth Raate was -17.10%. The current P/E ratio is 48.96, which is close to the five-year high of 53.120--something investors should be cautious of. Another warning sign is the stock's current P/B ratio of 3.87 is close to its 10-year high of 4.32. Lastly, the P/S ratio is 1.24 is close to its five-year high of 1.25.
Robbins purchased 629,647 shares of AGN at an average price of $199.25/share, which had a 0.67% impact on his portfolio.
Allergen was founded in 1950, but incorporated in Delaware in 1977 as a multi-specialty health care company that is focused on developing and commercializing pharmaceuticals, biologics and medical devices to help people live life to their greatest potentials.
The stock is currently trading at $233.16 and the Lynch earnings line is at $69.80, which indicates the stock may be overvalued.
For the past 12 months, the company's earnings per share was $4.92, with a growth rate of 1.70%. The P/E ratio is currently 54.38.
Revenue per share for the past 12 months was $23.24 with a growth rate at 15.60%. The company has shown predictable revenue and earnings growth, which is a good sign for shareholders.
The P/S ratio is 10.03 as of today and lose to the 10-year high of 9.94.
P/B ratio is at 9.76.
Robbins also increased his stakes in the following positions: eBay Inc (EBAY, Financial), Mohawk Industries Inc (MHK, Financial), VCA Inc (WOOF), CBS Corp (CBS, Financial), Avis Budget Group Inc (CAR, Financial), Brookdale Senior Living Inc (BKD), Endo International PLC (ENDP, Financial) and Teradyne Inc (TER).
To find out more on which companies Robbins increased his stakes in, click here for more information regarding his portolio.
To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for 7 days.
